- Home
- APLM vs QMCO Comparison
APLM vs QMCO Comparison
Compare APLM & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- QMCO
- Stock Information
- Founded
- APLM 2016
- QMCO 1980
- Country
- APLM United States
- QMCO United States
- Employees
- APLM N/A
- QMCO N/A
- Industry
- APLM Blank Checks
- QMCO Electronic Components
- Sector
- APLM Finance
- QMCO Technology
- Exchange
- APLM Nasdaq
- QMCO Nasdaq
- Market Cap
- APLM 15.6M
- QMCO 15.4M
- IPO Year
- APLM N/A
- QMCO N/A
- Fundamental
- Price
- APLM $0.14
- QMCO $3.38
- Analyst Decision
- APLM Strong Buy
- QMCO Hold
- Analyst Count
- APLM 2
- QMCO 1
- Target Price
- APLM $4.25
- QMCO N/A
- AVG Volume (30 Days)
- APLM 892.5K
- QMCO 24.7K
- Earning Date
- APLM 08-14-2024
- QMCO 10-18-2024
- Dividend Yield
- APLM N/A
- QMCO N/A
- EPS Growth
- APLM N/A
- QMCO N/A
- EPS
- APLM N/A
- QMCO N/A
- Revenue
- APLM $2,101,000.00
- QMCO $290,448,000.00
- Revenue This Year
- APLM N/A
- QMCO N/A
- Revenue Next Year
- APLM N/A
- QMCO $0.11
- P/E Ratio
- APLM N/A
- QMCO N/A
- Revenue Growth
- APLM 70.54
- QMCO N/A
- 52 Week Low
- APLM $0.11
- QMCO $2.22
- 52 Week High
- APLM $2.60
- QMCO $18.00
- Technical
- Relative Strength Index (RSI)
- APLM 49.47
- QMCO 43.92
- Support Level
- APLM $0.13
- QMCO $3.35
- Resistance Level
- APLM $0.17
- QMCO $3.56
- Average True Range (ATR)
- APLM 0.01
- QMCO 0.21
- MACD
- APLM 0.00
- QMCO 0.11
- Stochastic Oscillator
- APLM 37.93
- QMCO 49.80
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.